Scholarlink

Purpose <p>Artificial intelligence (AI) platforms are among the most prominent digital innovations in the contemporary time. The colossal growth and success of AI has garnered the attention of the scientific community and it is also being accepted in the public domain. The current review aims to provide in depth information about the utilization of AI in the pharmaceutical sector along with the limitations, ethical-legal aspects and future perspective of this technology in uplifting the growth of this sector. </p> Methods <p>The accredited web pages of PubMed, Google Scholar, Scopus and Web of Science were accessed using the terms “artificial intelligence” and “pharmaceutical”. Cross-referencing important articles yielded additional references which were evaluated and utilized for inclusion in writing this review.</p> Result <p>The dexterity of AI tools was explored in numerous domains of pharmaceutical sector like drug discovery, pharmaceutical product development, manufacturing, product management, clinical &amp; diagnostic field, 3D printing technology and community pharmacy. It was found that the augmentation of AI with pharmaceutical sector will lift the growth of this sector by heaps and bounds for the reason that every facet will be reshaped in terms of finances and time.</p> Conclusion <p>Significant developments in AI offers a revolutionary chance for drug discovery, formulation, clinical and diagnostic applications, 3D printing and plentiful applications in the pharmaceutical industry. However, AI presents risk factors and ethical concerns that must be handled before society, health systems, and individuals can fully benefit from it. Pharmaceutical developers should ensure that the AI tools and procedures comply with all ethical and regulatory standards enforced by the regulatory agencies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Artificial Intelligence: Preface, Applications and Future Perspective in Relation to Pharmaceutical Sector

  • 期刊论文

  • 发表日期：

    2025年3月6日

查看全文
  • Supriya Singh,
  • Sanket Kumar,
  • Sheikh Shahnawaz Quadir,
  • Saloni Bhandari,
  • Bhuvanesh Baniya,
  • Garima Joshi,
  • C. P. Jain,
  • Deepak Choudhary

摘要

Purpose

Artificial intelligence (AI) platforms are among the most prominent digital innovations in the contemporary time. The colossal growth and success of AI has garnered the attention of the scientific community and it is also being accepted in the public domain. The current review aims to provide in depth information about the utilization of AI in the pharmaceutical sector along with the limitations, ethical-legal aspects and future perspective of this technology in uplifting the growth of this sector.

Methods

The accredited web pages of PubMed, Google Scholar, Scopus and Web of Science were accessed using the terms “artificial intelligence” and “pharmaceutical”. Cross-referencing important articles yielded additional references which were evaluated and utilized for inclusion in writing this review.

Result

The dexterity of AI tools was explored in numerous domains of pharmaceutical sector like drug discovery, pharmaceutical product development, manufacturing, product management, clinical & diagnostic field, 3D printing technology and community pharmacy. It was found that the augmentation of AI with pharmaceutical sector will lift the growth of this sector by heaps and bounds for the reason that every facet will be reshaped in terms of finances and time.

Conclusion

Significant developments in AI offers a revolutionary chance for drug discovery, formulation, clinical and diagnostic applications, 3D printing and plentiful applications in the pharmaceutical industry. However, AI presents risk factors and ethical concerns that must be handled before society, health systems, and individuals can fully benefit from it. Pharmaceutical developers should ensure that the AI tools and procedures comply with all ethical and regulatory standards enforced by the regulatory agencies.